SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0001213900-19-000233
Filing Date
2019-01-07
Accepted
2019-01-04 21:47:30
Documents
18

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2231816
2 filename2.htm EX-21.1 607
3 filename3.htm EX-23.1 2658
4 GRAPHIC logo.jpg GRAPHIC 22261
5 GRAPHIC chart1.jpg GRAPHIC 71498
6 GRAPHIC chart2.jpg GRAPHIC 44788
7 GRAPHIC chart3.jpg GRAPHIC 48612
8 GRAPHIC chart4.jpg GRAPHIC 69767
9 GRAPHIC chart5.jpg GRAPHIC 44788
10 GRAPHIC chart6.jpg GRAPHIC 48612
11 GRAPHIC chart7.jpg GRAPHIC 69767
12 GRAPHIC chart8.jpg GRAPHIC 68430
13 GRAPHIC chart9.jpg GRAPHIC 44788
14 GRAPHIC chart10.jpg GRAPHIC 48612
15 GRAPHIC chart11.jpg GRAPHIC 49793
16 GRAPHIC chart12.jpg GRAPHIC 64439
17 GRAPHIC footer.jpg GRAPHIC 11261
18 GRAPHIC ex23-1_001.jpg GRAPHIC 22997
  Complete submission text file 0001213900-19-000233.txt   3244141
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-02455 | Film No.: 19512061
SIC: 2834 Pharmaceutical Preparations